Singapore markets closed
Straits Times Index
3,336.59 +13.21 (+0.40%) Nikkei
38,487.90 +433.80 (+1.14%) Hang Seng
18,079.61 -150.59 (-0.83%) FTSE 100
8,268.82 +37.77 (+0.46%) Bitcoin USD
68,313.27 +431.02 (+0.63%) CMC Crypto 200
1,432.02 +3.45 (+0.24%)
Novavax, Inc. (NVAX)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Pre-market:
| Previous close | 15.11 |
| Open | 15.00 |
| Bid | 15.21 x 2400 |
| Ask | 15.26 x 2400 |
| Day's range | 14.71 - 15.66 |
| 52-week range | 3.53 - 17.40 |
| Volume | |
| Avg. volume | 12,462,682 |
| Market cap | 2.246B |
| Beta (5Y monthly) | 1.62 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -3.05 |
| Earnings date | 06 Aug 2024 - 12 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 21.60 |
PR NewswireNovavax to Participate in 2024 Jefferies Global Healthcare Conference
Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced it will participate in the 2024 Jefferies Global Healthcare Conference.
ZacksHere is What to Know Beyond Why Novavax, Inc. (NVAX) is a Trending Stock
Zacks.com users have recently been watching Novavax (NVAX) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Barrons.comArbutus, Novavax See Activist Investor Action
Whitefort Capital wants biopharmaceutical firm Arbutus to stop issuing stock. Shah Capital ended a proxy campaign against biotech Novavax.
© 2024 Yahoo. All rights reserved.